Recombinant IL13 (Lebrikizumab Biosimilar) anticorps

N° du produit ABIN7829211

Cet anticorps anti-IL13 (Lebrikizumab Biosimilar) Monoclonal Humanized (ABIN7829211) détecte spécifiquement IL13 (Lebrikizumab Biosimilar). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant IL13 (Lebrikizumab Biosimilar) anticorps (ABIN7829211)

Antigène: IL13 (Lebrikizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp IL13 (Lebrikizumab Biosimilar) est non-conjugé

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-IL13 (Lebrikizumab Biosimilar) anticorps

Fonction: Anti-IL13(lebrikizumab biosimilar) mAb

Isotype: IgG4

Information d'application

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur IL13 (Lebrikizumab Biosimilar)

Antigène: IL13 (Lebrikizumab Biosimilar)

Autre désignation: Lebrikizumab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:P600,IL-13,NC30
Synonyms Antibody:DRM 06,DRM-06,DRM06,DRM 6,DRM-6,DRM6,LY 3650150,LY-3650150,LY3650150,MILR1444A,MILR-1444A,MILR 1444,ARG 3637,ARG-3637,ARG3637,RO 5490255,RO-5490255,RO5490255,TNX 650,TNX-650,TXN650

UniProt: P35225